Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478

Lignende værker

• Dianthin and Its Potential in Targeted Tumor Therapies
  af: Hendrik Fuchs
  Udgivet: (2019-10-01)
• Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861
  af: Anie P. Masilamani, et al.
  Udgivet: (2023-07-01)
• Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478
  af: Hossein Panjideh, et al.
  Udgivet: (2022-10-01)
• A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
  af: Finn J. Schulze, et al.
  Udgivet: (2024-04-01)
• Magnetic Nanoparticle-Based Dianthin Targeting for Controlled Drug Release Using the Endosomal Escape Enhancer SO1861
  af: Ajmal Zarinwall, et al.
  Udgivet: (2021-04-01)